Fresenius Helios

Fresenius Helios is Europe’s largest private hospital operator, offering expertise in all areas and at all levels of clinical care. It is also a provider of ambulatory care with a strong services network. Fresenius Helios ­carries responsibility for approximately 20 million patients who undergo medical treatment with it every year.

Highlights 2020

Swiftly and with strong commitment, Fresenius Helios made significant contributions to combat the COVID-19 pandemic in 2020.

In Spain, Quirónsalud treated around 13% of the country’s total COVID-19 patients during the first wave of the pandemic. To contribute to transparency and data-based evaluation, Helios Germany publishes the bed utilization in each of its hospitals on a daily basis.

The German federal government created financial shields

to indemnify hospital providers against the suspension of elective procedures and increased costs for treating COVID-19 patients. However, the hospitals were not fully compensated for forgone treatments and increased costs. In Spain, we were compensated for additional costs related to COVID-19 patients.

Our digital health platform Curalie

offers treatment support for inpatient and ambulatory care as well as prevention.

Helios Germany acquired four hospitals and six medical care centers

from the Malteser humanitarian aid group. The facilities have a total of ~1,300 beds and had sales of about €230 million in 2019, and are an excellent fit for Fresenius Helios’ strategy of building specialized centers within regional clusters.

The acquisition of Eugin Group adds a global network of fertility clinics to Fresenius Helios.

Eugin offers substantial organic and non-organic growth opportunities. It had sales of about €160 million in 2019 and is expected to be accretive to Fresenius’ net income in 2021.

Comprehensive inpatient and outpatient care

Fresenius Helios comprises Helios Germany and Helios Spain (Quirónsalud); both are part of the holding company Helios Health.

Our extensive expertise and know-how in ensuring high-quality, efficient, and patient-focused health care are exchanged across borders. This mutual knowledge transfer aims to continuously optimize the care of our patients.

Helios Germany

Helios Germany operates 89 hospitals, around 130 out­patient clinics, and 6 prevention centers. It is the largest provider of inpatient and outpatient care in Germany.

Helios Spain (Quirónsalud)

Quirónsalud operates 46 hospitals, 70 outpatient centers, and around 300 occupational risk prevention centers. It is the largest private hospital operator in Spain. The company offers comprehensive health care that encompasses all medical specialties. In addition, the company is active in Latin America with 6 hospitals and as a provider of medical diagnostics.

The platform Curalie bundles the digital offerings of Fresenius Helios. Curalie’s support tools are specifically designed to treat chronically ill patients.

Our success factors

  • Focus on patients’ safety and satisfaction
  • Leading market positions
  • Achieving measurable, high-quality standards of medicine
  • Future-oriented workplace
  • Strong hospital network and development of centers of excellence
  • Digital support tools for patient treatment

Our growth drivers

  • Organic growth through growing patient admissions and increasing prices for hospital services
  • Growth opportunities in the outpatient sector and development of new patient care models
  • Increasing digital connectivity with patients
  • Carrying out greenfield projects
  • Providing development opportunities for doctors and nurses
  • Selective inorganic growth

Market dynamics

Hospital market in Germany

~ € 109 bn

Private hospital market in Spain

~ € 16 bn

Length of stay below the average

of 7.2 days

in Germany provides benefits for ­hospital operators (Helios Germany: 5.7 days)

Average increase of private health insurance policies in Spain of

~ 2.5% p.a.

Inpatient treatments could be performed by

25%

in outpatient settings.
An increased focus on ambulatory care offers chances for hospital operators.

Relatively low average of

2.5

hospital beds in Spain (per 1,000 inhabitants) provides opportunities for growth

Download (XLSX, 35 KB)
Key hospital indicators
2020 2019 Change
Acute clinics Germany 86 83 +4%
Beds 29,451 28,380 +4%
Acute clinics Spain and Latin America 52 50 +4%
Beds 7,936 7,288 +9%
Patient numbers Germany 5,151,717 5,566,613 -7%
Patients treated in ­hospital 1,044,959 1,206,654 -13%
Patients treated as ­outpatients 4,101,716 4,354,527 -6%
Patient numbers Spain and Latin America 15,037,804 15,396,051 -2%
Patients treated in ­hospital 927,414 845,560 +10%
Patients treated as ­outpatients 14,110,390 14,550,491 -3%

Sales and earnings development

Download (XLSX, 35 KB)
Germany
in € millions 2020 2019 Change Change in constant currency
Sales 6,340 5,940 +7% +7%
EBIT 602 577 +4% +4%
Employees 73,757 68,688 +7%
Download (XLSX, 35 KB)
Spain (including Latin America)
in € millions 2020 2019 Change Change in constant currency
Sales 3,475 3,292 +6% +5%
EBIT 420 443 -5% -5%
Employees 43,195 37,689 +15%

Source:
Hospital market in Germany ~ € 109 bn

Length of stay below the average of 7.2 days in Germany provides benefits for hospital operators (Helios Germany: 5.7 days)
Source: German Federal Statistical Office, 2018 data (most recent market data available refers to the year 2018 as no more recent data have been published); own research Helios Germany

Outpatient treatment
Source: Bertelsmann Stiftung, Spotlight Gesundheit, 2019, Ärztliche Vergütung

Private hospital market in Spain ~ € 16 bn
Source: Market data based on own research and refer to the addressable market for Quirónsalud.

Average increase of private health insurance policies in Spain of ~ 2.5% p.a.
Source: Asociación ICEA (Investigación Cooperativa entre Entidades Aseguradoras y Fondos de Pensiones), Data from 2011 to 2019

Relatively low average of 2.5 hospital beds in Spain (per 1,000 inhabitants) provides opportunities for growth
Source: OECD Health Data, 2018 data (most recent market data available refers to the year 2018 as no more recent data have been published)

Fresenius Kabi

Fresenius Vamed